Life Sciences (International Firms)
Greater China Region Guide 2024 : China
Band 3
Contact number
+86 21 2322 5200About
Provided by Morrison Foerster
MoFo has one of the most highly regarded life sciences + Healthcare practices in Asia. We work with innovators at every phase of their growth cycle, from conception to commercialization and exit, vigilantly protecting and enforcing their rights in competitive markets.
We count among our clients some of the leading names in the biotechnology, pharmaceutical, and healthcare industries, and some of the fastest growing companies at the intersection of life sciences and data analytics. Our team includes attorneys and patent agents with more than 100 advanced scientific and engineering degrees, including 65 Ph.D.s in life sciences and related engineering disciplines.
Chambers Review
The China life sciences department at Morrison Foerster LLP possesses strong technical abilities and broad industrial experience. Its key areas of focus include IP and due diligence matters. The team advises clients on IP prosecution and portfolio management. It is well versed at handling corporate matters including outbound investments, commercial partnerships, joint ventures and M&A deals. The firm counts a number of public and private companies, as well as investment firms, among its clients, including Jiangsu Hengrui Medicine and Triastek.
Gordon Milner, Thomas Chou and Sun Chuan are key contacts for clients.
Work Highlights
- Morrison Foerster advised Tate & Lyle on its USD237 million acquisition of a prebiotic dietary fibre company Quantum Hi-Tech (Guangdong) Biological.
Strengths
Provided by Chambers
"The team provides immediate responses, and is open to working with us to accommodate any of our time zone issues."
"Morrison Foerster's team has deep knowledge, and it knows the company and stakeholders well."
"The team provides immediate responses, and is open to working with us to accommodate any of our time zone issues."
"Morrison Foerster's team has deep knowledge, and it knows the company and stakeholders well."